Persian Heritage Image Binarization Competition (PHIBC 2012)

The first competition on the binarization of historical Persian documents and manuscripts (PHIBC 2012) has been organized in conjunction with the first Iranian conference on pattern recognition and image analysis (PRIA 2013). The main objective of PHIBC 2012 is to evaluate performance of the binarization methodologies, when applied on the Persian heritage images. This paper provides a report on the methodology and performance of the three submitted algorithms based on evaluation measures has been used.Comment: 4 pages, 2 figures, conferenc

A Set of Criteria for Face Detection Preprocessing

AbstractThe goal of this paper is to provide a robust set of preprocessing steps to be used with any face detection system. Usually, the purpose of using preprocessing steps in face detection system is to speed up the detection process and reducing false positives. A preprocessing step should reject an acceptable amount of non-face windows. First proposed criterion is based on linear image transform (LIT) which ignores scanning a number of non-face windows. Second criterion utilizes regional minima (RM) to reject non-face windows. The last one uses a modified adaptive thresholding (ADT) technique to convert input image into a binary representation and perform an exclusion process on the latter form. The proposed criteria have been used in conjunction with a version of Viola-Jones face detector. Experimental results show significant advantage against early exclusion criterion or variance classifier in terms of speed and rejection rate. CMU-MIT and BioID datasets have been used in the experiments

Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019Research in context

Summary: Background: The causes for immune-mediated inflammatory diseases (IMIDs) are diverse and the incidence trends of IMIDs from specific causes are rarely studied. The study aims to investigate the pattern and trend of IMIDs from 1990 to 2019. Methods: We collected detailed information on six major causes of IMIDs, including asthma, inflammatory bowel disease, multiple sclerosis, rheumatoid arthritis, psoriasis, and atopic dermatitis, between 1990 and 2019, derived from the Global Burden of Disease study in 2019. The average annual percent change (AAPC) in number of incidents and age standardized incidence rate (ASR) on IMIDs, by sex, age, region, and causes, were calculated to quantify the temporal trends. Findings: In 2019, rheumatoid arthritis, atopic dermatitis, asthma, multiple sclerosis, psoriasis, inflammatory bowel disease accounted 1.59%, 36.17%, 54.71%, 0.09%, 6.84%, 0.60% of overall new IMIDs cases, respectively. The ASR of IMIDs showed substantial regional and global variation with the highest in High SDI region, High-income North America, and United States of America. Throughout human lifespan, the age distribution of incident cases from six IMIDs was quite different. Globally, incident cases of IMIDs increased with an AAPC of 0.68 and the ASR decreased with an AAPC of −0.34 from 1990 to 2019. The incident cases increased across six IMIDs, the ASR of rheumatoid arthritis increased (0.21, 95% CI 0.18, 0.25), while the ASR of asthma (AAPC = −0.41), inflammatory bowel disease (AAPC = −0.72), multiple sclerosis (AAPC = −0.26), psoriasis (AAPC = −0.77), and atopic dermatitis (AAPC = −0.15) decreased. The ASR of overall and six individual IMID increased with SDI at regional and global level. Countries with higher ASR in 1990 experienced a more rapid decrease in ASR. Interpretation: The incidence patterns of IMIDs varied considerably across the world. Innovative prevention and integrative management strategy are urgently needed to mitigate the increasing ASR of rheumatoid arthritis and upsurging new cases of other five IMIDs, respectively. Funding: The Global Burden of Disease Study is funded by the Bill and Melinda Gates Foundation. The project funded by Scientific Research Fund of Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital (2022QN38)